...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: Rumors starting again

fuzzyjr - I don't know where the rumours are coming from but have heard too many times directly what wasn't supposed to be rumours not come true that I am not wasting my time on them. 

As far as tax implications, if a deal that had tax implications happened before year end, it probably wouldn't close until after year end so would be 2021 taxes. 

Share
New Message
Please login to post a reply